Adaptive Phage Therapeutics' Seed Round

Adaptive Phage Therapeutics raised a round of funding on April 14, 2017. Investors include Maryland Technology Development Corporation.

Adaptive Phage Therapeutics (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. Two key compone…

Articles about Adaptive Phage Therapeutics' Seed Round: